Pharmaceutical giant Gilead Sciences has agreed to donate drugs that reduce the risk of HIV transmission for up to 200,000 people a year, the Trump administration says.
The agreement between Gilead and the Trump administration will last until at least Dec. 31, 2025, and possibly through the end of 2030, Health and Human Services Secretary Alex Azar said in a statement Thursday. Gilead will donate its PrEP medication Truvada, which is used to reduce the risk of HIV infection and usually sells for $1,600 to $2,000 a month in the United States.
The deal will “help us achieve our goal of ending the HIV epidemic in America!,” President Donald Trump said in a tweet.
About the Author
Beautiful
In other words, an overpriced Porta Potty .
This year’s recommendation to take the flu shot is not based on science. Here’s a link to an article about…
Looks like a nice unit, one to be proud of. Just wondering about the final total costs: $69,165°° plus (???)…
We know the January 6,2021 protesters consisted of FBI disguised as MAGA and others were paid to attend by George…